Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 101.85B | 102.56B | 101.89B | 99.46B | 110.67B | 112.94B |
Gross Profit | 25.73B | 25.38B | 28.14B | 27.61B | 31.68B | 32.48B |
EBITDA | 2.67B | 1.73B | 3.62B | 3.57B | 3.95B | 5.00B |
Net Income | -1.83B | -2.62B | 451.00M | 205.00M | 368.00M | 878.00M |
Balance Sheet | ||||||
Total Assets | 58.60B | 55.58B | 58.19B | 54.26B | 49.37B | 50.90B |
Cash, Cash Equivalents and Short-Term Investments | 6.49B | 5.75B | 6.03B | 5.35B | 6.15B | 7.72B |
Total Debt | 14.02B | 15.31B | 15.58B | 10.42B | 5.29B | 5.48B |
Total Liabilities | 31.40B | 29.61B | 29.33B | 25.63B | 20.56B | 22.17B |
Stockholders Equity | 27.20B | 25.97B | 28.86B | 28.63B | 28.81B | 28.73B |
Cash Flow | ||||||
Free Cash Flow | 0.00 | 1.71B | -2.79B | -4.37B | -887.00M | 1.27B |
Operating Cash Flow | 0.00 | 3.32B | 1.63B | 1.93B | 2.25B | 5.69B |
Investing Cash Flow | 0.00 | -2.40B | -3.54B | -7.13B | -3.11B | -3.60B |
Financing Cash Flow | 0.00 | -1.20B | 2.60B | 4.40B | -699.00M | -1.55B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
79 Outperform | ¥10.51B | 7.03 | 2.36% | 15.66% | 2.87% | ||
76 Outperform | ¥11.96B | 11.39 | 1.11% | 6.01% | -21.51% | ||
74 Outperform | ¥9.09B | 9.24 | 2.98% | 2.42% | 154.96% | ||
70 Outperform | ¥11.00B | 6.96 | 1.46% | 0.19% | 32.51% | ||
65 Neutral | $27.28B | 15.30 | -4.01% | 3.16% | 1.00% | 1.98% | |
54 Neutral | ¥12.72B | ― | 2.31% | 0.65% | -679.30% | ||
41 Neutral | ¥9.44B | ― | ― | -5.60% | -23.60% |